The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance.
O'Kane, Grainne M
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 05 2019 - 86-89 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-8332
10.1016/j.lungcan.2019.03.019 doi
Acrylamides--therapeutic use
Alleles
Aniline Compounds--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Circulating Tumor DNA--genetics
Disease Progression
Drug Resistance, Neoplasm--genetics
ErbB Receptors--genetics
Female
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms--drug therapy
Male
Mutation--genetics
Neoplasm Staging
Polymorphism, Genetic
Prospective Studies
Protein Kinase Inhibitors--therapeutic use
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 05 2019 - 86-89 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-8332
10.1016/j.lungcan.2019.03.019 doi
Acrylamides--therapeutic use
Alleles
Aniline Compounds--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Circulating Tumor DNA--genetics
Disease Progression
Drug Resistance, Neoplasm--genetics
ErbB Receptors--genetics
Female
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms--drug therapy
Male
Mutation--genetics
Neoplasm Staging
Polymorphism, Genetic
Prospective Studies
Protein Kinase Inhibitors--therapeutic use